Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EZH2-Regulated DAB2IP Is a Medulloblastoma Tumor Suppressor and a Positive Marker for Survival

13 Jun 2012

Abstract excerpt

PURPOSE: Medulloblastoma is the most common malignant brain tumor in children. Despite recent improvements, the molecular mechanisms driving medulloblastoma are not fully understood and further elucidation could provide cues to improve outcome prediction and therapeutic approaches. EXPERIMENTAL DESIGN: Here, we conducted a meta-analysis of mouse and human medulloblastoma gene expression data sets, to identify...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Syndromes and Imprinting
Share to Glioma Diagnosis and Treatment
Share to Microtubule and mitosis dynamics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22696229
DOI: 10.1158/1078-0432.ccr-12-0399

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EZH2-Regulated DAB2IP Is a Medulloblastoma Tumor Suppressor and a Positive Marker for SurvivalPMID 22696229Read ↗

New Approaches in Targeted Therapy for Medulloblastoma in ChildrenSemantic proximity Read ↗

Hijacking a neurodevelopmental epigenomic program in metastatic dissemination of medulloblastomaSemantic proximity Read ↗

MiR-212-3p functions as a tumor suppressor gene in group 3 medulloblastoma via targeting Nuclear Factor I/B (NFIB)Semantic proximity Read ↗

The Neurodevelopmental and Molecular Landscape of Medulloblastoma Subgroups: Current Targets and the Potential for Combined TherapiesSemantic proximity Read ↗

Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological FeaturesSemantic proximity Read ↗

Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas.Semantic proximity Read ↗

Identification of hub genes and potential molecular mechanisms in medulloblastoma by integrated bioinformatics analysisSemantic proximity Read ↗

Integrated Analysis of Transcriptome Data Revealed AURKA and KIF20A as Critical Genes in Medulloblastoma ProgressionSemantic proximity Read ↗

An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fateSemantic proximity Read ↗

Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future TherapeuticsSemantic proximity Read ↗

A molecular fingerprint for medulloblastoma.Semantic proximity Read ↗

Characterization of an RNA binding protein interactome reveals the targetable post-transcriptional landscape of MYC-amplified medulloblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.